Lipopolysaccharide (Porphyromonas gingivalis)
Catalog Number: LPS0002
Price: Online Inquiry
Catalog Number: LPS0002
Price: Online Inquiry
| Product Information | |
|---|---|
| Size | 1mg |
| Description | As an inducer, it stimulates acute lung injury in human bronchial epithelial (HBE) cells; as an agonist for Toll-like receptor 4 (TLR4) and stimulates normal fibroblasts in the intestine (NF), research on fibroblast osteopontin (OPN) expression; study its effects on the expression of pro-inflammatory and pro-coagulant genes in endothelial cells. Purification method: Phenol extraction. |
| Appearance | White to pale yellow lyophilized powder |
| Content | Protein content < 3% |
| Source | Porphyromonas gingivalis |
| Properties | |
|---|---|
| Storage Conditions | Store at 2-8℃. |
| Shipping Conditions | Refrigerated Transport |
Porphyromonas gingivalis is a gram-negative bacterium associated with adult periodontitis. The lipopolysaccharide (LPS) is a characteristic component of the cell wall of gram-negative bacterium Porphyromonas gingivalis. It differs in structure and various functions from lipopolysaccharide derived from Escherichia coli. Studies have shown that lipopolysaccharides derived from Escherichia coli and Porphyromonas gingivalis have different regulatory mechanisms for the surface expression of cluster of differentiation 14 (CD14), toll-like receptor 2 (TLR2), and toll-like receptor 4 (TLR4), as well as for the primary and secondary cytokine responses.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.